Daiichi Sankyo Co., Ltd. (DSNKY)
17.97
+0.07
(+0.39%)
USD |
OTCM |
Nov 13, 16:00
Daiichi Sankyo Enterprise Value : 31.74B for Nov. 13, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 31.74B |
| November 12, 2026 | 31.61B |
| November 11, 2026 | 30.90B |
| November 10, 2026 | 31.21B |
| November 09, 2026 | 32.19B |
| November 06, 2026 | 31.54B |
| November 05, 2026 | 33.80B |
| November 04, 2026 | 33.29B |
| November 03, 2026 | 32.06B |
| November 02, 2026 | 32.14B |
| October 30, 2026 | 30.77B |
| October 29, 2026 | 29.17B |
| October 28, 2026 | 28.69B |
| October 27, 2026 | 28.97B |
| October 26, 2026 | 31.59B |
| October 23, 2026 | 31.50B |
| October 22, 2026 | 31.99B |
| October 21, 2026 | 31.61B |
| October 20, 2026 | 31.65B |
| October 19, 2026 | 30.50B |
| October 16, 2026 | 30.30B |
| October 15, 2026 | 29.62B |
| October 14, 2026 | 29.17B |
| October 13, 2026 | 29.24B |
| October 12, 2026 | 29.46B |
| Date | Value |
|---|---|
| October 09, 2026 | 29.51B |
| October 08, 2026 | 29.91B |
| October 07, 2026 | 30.24B |
| October 06, 2026 | 30.79B |
| October 05, 2026 | 30.64B |
| October 02, 2026 | 30.66B |
| October 01, 2026 | 30.53B |
| September 30, 2026 | 31.45B |
| September 29, 2026 | 31.90B |
| September 28, 2026 | 32.19B |
| September 25, 2026 | 33.14B |
| September 24, 2026 | 32.43B |
| September 23, 2026 | 33.49B |
| September 22, 2026 | 33.74B |
| September 21, 2026 | 33.74B |
| September 18, 2026 | 33.56B |
| September 17, 2026 | 33.45B |
| September 16, 2026 | 32.16B |
| September 15, 2026 | 32.45B |
| September 14, 2026 | 32.65B |
| September 11, 2026 | 32.09B |
| September 10, 2026 | 30.99B |
| September 09, 2026 | 31.12B |
| September 08, 2026 | 31.69B |
| September 04, 2026 | 31.94B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 94.93B |
| Eisai Co., Ltd. | 8.931B |
| Chugai Pharmaceutical Co., Ltd. | 68.64B |
| Santen Pharmaceutical Co., Ltd. | 3.756B |
| Ono Pharmaceutical Co., Ltd. | 6.362B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 530.10M |
| Revenue (Quarterly) | 3.720B |
| Total Expenses (Quarterly) | 3.200B |
| EPS Diluted (Quarterly) | 0.2857 |
| Gross Profit Margin (Quarterly) | 79.49% |
| Profit Margin (Quarterly) | 14.25% |
| Earnings Yield | 5.79% |
| Operating Earnings Yield | 5.58% |
| Normalized Earnings Yield | 5.795 |